|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 35/17 | |||
| C07K 14/725 | |||
| C07K 14/705 | |||
| C07K 19/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3186280 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15760045.3 |
| Europos patento paraiškos padavimo data | 2015-08-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/047606 |
| Data | 2015-08-28 |
| (87) | Numeris | WO 2016/033570 |
| Data | 2016-03-03 |
| (30) | Numeris | Data | Šalis |
| 201462043273 P | 2014-08-28 | US | |
| 201462078942 P | 2014-11-12 | US |
| (72) |
CHEN, Yan, US
SHAMAH, Steve, US
PAZMANY, Csaba, US
DUTTA-SIMMONS, Jui, US
|
| (73) |
Juno Therapeutics, Inc.,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19 |
| ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19 |